Does hyperinsulinemia preserve bone?
Hyperinsulinemia may be responsible for part of the observed association of both diabetes and obesity with BMD in women.
Our study highlights the utility of a novel companion diagnostics technology, CEER that has strong implications for drug development and therapeutic monitoring. CEER is used to provide an increased understanding of activated signaling pathways in advanced GCs that can significantly improve their clinical management through accurate patient selection for targeted therapeutics.